Evolv Technologies: Growth Story Tempered by Control Weaknesses and Valuation Risk

What happened

Evolv Technologies' AI-based weapons detection business continues to grow, with revenue up 57% YoY in Q3 2025 and ARR reaching $117.2 million, but the growth is increasingly driven by non-recurring items and a winding-down licensing channel. Meanwhile, material internal control weaknesses and ongoing regulatory investigations, including an FTC order and securities class actions, cast doubt on the quality and sustainability of reported results. A Seeking Alpha analysis underscores these risks, setting a fair value of $6.59 per share and highlighting that near-term free cash flow remains limited while valuation is highly sensitive to assumptions. The DeepValue master report assigns a 'POTENTIAL SELL' rating, with a base case of $7.00, noting that the market is pricing in a smooth growth trajectory that management's own 2026 guidance (low-teens revenue growth) contradicts. With a market cap of roughly $1.17 billion and negative GAAP earnings, the stock offers limited margin of safety, and any disappointment on growth, margins, or legal outcomes could trigger significant downside.

Implication

The convergence of accounting weaknesses, legal overhangs, and decelerating growth in 2026 (management guides 11-13% revenue growth) suggests that current valuation of ~7x forward revenue does not adequately compensate for the risks. Subscription gross margins have declined to 52% due to equipment disposal and field service costs, and product margins remain deeply negative, indicating that unit economics are still fragile. With only $56 million in cash and marketable securities against a capital-intensive leasing model and potential legal settlements, the balance sheet provides limited cushion. Insider buying in late November 2025 at around $6.00 offers some confidence, but it is not a sufficient catalyst to override the structural concerns. The most prudent course is to treat any strength near $9.00 as a trim opportunity and wait for a more attractive entry point near the bear case of $4.50-$5.50 to build a position with better risk/reward.

Thesis delta

The investment thesis has shifted from a high-growth, de-risked AI security platform to a story where growth is slowing, profitability is still adjusted, and unresolved control and legal issues loom large. The DeepValue report's 'POTENTIAL SELL' rating reflects that the market's optimistic assumptions are not supported by the underlying fundamentals, and the margin of safety is insufficient. Any positive inflection in the next 6-12 months would require clear evidence of control remediation, better unit economics, and a resolution of legal costs, which are not yet in hand.